0001104659-21-044238.txt : 20210331
0001104659-21-044238.hdr.sgml : 20210331
20210331060155
ACCESSION NUMBER: 0001104659-21-044238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210326
FILED AS OF DATE: 20210331
DATE AS OF CHANGE: 20210331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SOFINNOVA CAPITAL VI FCPR
CENTRAL INDEX KEY: 0001441261
STATE OF INCORPORATION: XX
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38869
FILM NUMBER: 21789633
BUSINESS ADDRESS:
STREET 1: C/O SOFINNOVA PARTNERS
STREET 2: 17 RUE DE SURENE
CITY: PARIS
STATE: XX
ZIP: 75008
BUSINESS PHONE: 33 1 53 054100
MAIL ADDRESS:
STREET 1: C/O SOFINNOVA PARTNERS
STREET 2: 17 RUE DE SURENE
CITY: PARIS
STATE: XX
ZIP: 75008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofinnova Partners SAS
CENTRAL INDEX KEY: 0001574139
STATE OF INCORPORATION: I0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38869
FILM NUMBER: 21789632
BUSINESS ADDRESS:
STREET 1: 17 RUE DE SERENE
CITY: PARIS
STATE: I0
ZIP: 75008
BUSINESS PHONE: 33 1 53 05 41 13
MAIL ADDRESS:
STREET 1: 17 RUE DE SERENE
CITY: PARIS
STATE: I0
ZIP: 75008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HOOKIPA Pharma Inc.
CENTRAL INDEX KEY: 0001760542
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 815395687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 0114318906360
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
4
1
tm2111073-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-03-26
0
0001760542
HOOKIPA Pharma Inc.
HOOK
0001441261
SOFINNOVA CAPITAL VI FCPR
C/O HOOKIPA PHARMA INC., 350 FIFTH,
AVENUE,72ND FLOOR, SUITE 7240
NEW YORK
NY
10118
0
0
1
0
0001574139
Sofinnova Partners SAS
C/O HOOKIPA PHARMA INC., 350 FIFTH,
AVENUE,72ND FLOOR, SUITE 7240
NEW YORK
NY
10118
0
0
1
0
Common Stock
2021-03-26
4
S
0
35171
13.6943
D
3543023
D
Shares sold pursuant to a Rule 10b5-1 trading plan dated September 30, 2020 previously adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.27 to $14.03, inclusive. The reporting person undertakes to provide to Hookipa Pharma Inc., any security holder of Hookipa Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.
/s/ Monique Saulnier, Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SAS
2021-03-30